IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates

  • IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.04 per share a year ago.